1) faropenem sodium
法罗培南钠
1.
A new carbepenem antimicrobial: faropenem sodium;
新型青霉烯类抗生素法罗培南钠
2.
RP- HPLC assay of faropenem sodium and its related substances;
HPLC法测定法罗培南钠含量及有关物质
3.
A HPLC method for determination of related substances of faropenem sodium;
法罗培南钠中有关物质测定方法的建立
2) faropenem sodium tablets
法罗培南钠片
1.
Double-blind randomized controlled multicenter clinical trial of faropenem sodium tablets in the treatment of acute bacterial infections;
法罗培南钠片治疗急性细菌性感染随机双盲对照临床研究
2.
A randomized,double-blind and parallel control clinical study to evaluate faropenem sodium tablets versus cefuroxime axetil tablets in the treatment of respiratory bacterial infections;
法罗培南钠片与头孢呋辛酯片治疗呼吸道细菌性感染135例
3.
Study on dissolution of faropenem sodium tablets by UV spectrophotometry;
紫外分光光度法测定法罗培南钠片的溶出度
3) faropenem sodium for injection
注射用法罗培南钠
1.
Conclusion Max tolerable dose of faropenem sodium for injection is 800 mg,a recommendeddose for phase Ⅱ clinical trial is 200 mg,tid.
目的确定注射用法罗培南钠(碳青霉烯类抗生素)最大耐受剂量及其连续给药的药代动力学研究。
4) Faropenem
法罗培南
1.
Antibacterial activity of faropenem for injection in vivo;
注射用法罗培南的体内抗菌活性
2.
Determination of faropenem for injection in human plasma and urine by high performance liquid chromatography;
高效液相色谱法测定注射用法罗培南在健康人血浆和尿中的浓度
5) Meropenem
美罗培南
1.
An Improving Meropenem Infusion Scheme Therapy for Acinetobacter baumannii Pneumonia in ICU:A Clinical Analysis;
改良美罗培南输注方案治疗ICU获得性鲍氏不动杆菌肺炎临床分析
2.
Efficaly of Meropenem Against Infections:A Clinical Evaluation of 2732 Cases;
美罗培南临床应用2732例的疗效评价
3.
Determination of meropenem in human serum and displacement liquid by HPLC;
高效液相色谱法测定人血清和置换液中美罗培南浓度
6) faropenem
呋罗培南
1.
Synthesis of the key intermediate of faropenem:(3S,4R)-3-[( R )-1-tert butyldimethylsilyloxyethyl]-4-[(R) tetrahydrofuranoylthio]-2-azetidinone;
呋罗培南中间体4-[(R)-四氢呋喃-2-甲酰硫基]-氮杂环丁-2-酮的合成
补充资料：法罗培南钠
分子式：C12H14NNaO5S
分子量：307.30
CAS号：122547-49-3
性质：
分子量：307.30
CAS号：122547-49-3
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条